Am J Transplant, Volume 22, Suppl 3 Archives - ATC Abstracts

2022 American Transplant Congress
Diabetes is a Significant and Independent Predictor for Tacrolimus Immediate Release (IR) and LCP-Tacrolimus (LCP) Conversion Ratios
K. S. Coffman, N. Patel, F. Bartlett, J. Newman, S. Patel, T. Sprague, N. Rao, E. Andrade, M. Casey, V. Rohan, D. DuBay, D. Taber
Medical University of South Carolina, Charleston, SC
*Purpose: Diabetes (DM) is a common comorbidity seen in transplant patients with known effects on GI motility and absorption; however, DMs impact on the IR…
2022 American Transplant Congress
Effect Of The SRTR COVID-19 3-month Carve-out On Program-specific Transplant Outcome Evaluations
J. Miller¹, G. R. Lyden¹, D. Zaun¹, B. Kasiske², R. Hirose³, A. Israni², J. Snyder¹
¹Scientific Registry of Transplant Recipients, Minneapolis, MN, ²Hennepin County Medical Center, Minneapolis, MN, ³University of California, San Francisco, San Francisco, CA
*Purpose: The SRTR January 2022 program evaluations (Jan 2022 program-specific reports [PSRs]) applied a COVID-19 carve-out where follow-up for transplants performed before March 13, 2020,…
2022 American Transplant Congress
Sensitization and BK Viremia; Risk Following Sub-Clinical COVID-19 Infection in Pediatric Kidney Transplant Recipients
E. Benz¹, M. Chandran², J. Chuita¹, K. McKinnon¹, A. Sikora¹, M. Bock¹, E. Blanchette¹
¹Children's Hospital Colorado, Aurora, CO, ²University of North Carolina, Chapel Hill, NC
*Purpose: In contrast to high morbidity and mortality of COVID-19 infection (COVIDi) in adult kidney transplant (KT) recipients, these sequelae appear to be muted in…
2022 American Transplant Congress
Utility of Four-Point Mycophenolate Mofetil Testing in a Pediatric Kidney Transplant Population
S. Sadiq, P. Brakeman, J. Brennan, E. Black
Pediatric Nephrology, UCSF, San Francisco, CA
*Purpose: While there is randomized, multicenter data in adults that area under the time concentration curve (AUC) measurements for Mycophenolate Mofetil (MMF) can direct dosing…
2022 American Transplant Congress
Outcomes After Deceased Donor Kidney Transplantation Utilizing Kidney Allografts with Marginal Perfusion Parameters: A Single-Center Experience
P. N. Chotai¹, A. Logan², F. Siddiqui³, A. Schenk⁴, G. Bumgardner⁵, G. L. Brock², A. El-Hinnawi⁵, A. Rajab⁶, K. Washburn⁷, N. Singh²
¹Division of Transplantation, Department of General Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, ²The Ohio State University Wexner Medical Center, Columbus, OH, ³Ohio State University, Bloomfield, NJ, ⁴Ohio State University Wexner Medical Center, Bexley, OH, ⁵Ohio State University, Columbus, OH, ⁶Ohio State University Wexner Medical Center, Columbus, OH, ⁷The Ohio State University, Columbus, OH
*Purpose: To study outcomes of deceased donor kidney transplantation (DDKT) in recipients of kidney allografts with poor perfusion parameters.*Methods: This is a retrospective, single center…
2022 American Transplant Congress
Pediatric Kidney Transplant Delays Due To Respiratory Viruses: A Provider Survey
T. A. Heald-Sargent¹, S. Manz², T. Barton³, P. Verghese⁴
¹Pediatric Infectious Diseases, Lurie Children's Hospital/Northwestern University, Chicago, IL, ²Central Michigan University, Mount Pleasant, MI, ³Pediatric Infectious Diseases, UT Health San Antonoio, San Antonio, TX, ⁴Pediatric Nephrology, Lurie Children's Hospital/Northwestern University, Chicago, IL
*Purpose: This study aimed to characterize the management and impact of respiratory viral infections on pediatric kidney transplantation waitlisted candidates.*Methods: An IRB-approved, anonymous REDCap survey…
2022 American Transplant Congress
Changes in Cold Ischemia Time and Transplantation Practices with the Concentric Model of Kidney Allocation
C. M. Puttarajappa¹, P. Sood¹, A. Tevar¹, V. Gunabushanam¹, S. Hariharan¹, S. Mohan²
¹University of Pittsburgh Medical Center, Pittsburgh, PA, ²Columbia University, New York, NY
*Purpose: Evaluate impact of the new concentric kidney allocation system (KAS250) on kidney utilization, allocation practices and cold ischemia time (CIT).*Methods: Using data from the…
2022 American Transplant Congress
Validation of the PROMIS® Medication Adherence Scale Among Kidney Transplant Recipients on Tacrolimus
J. D. Peipert¹, R. Slay², B. Smith², D. Cella¹, A. Keys², D. Taber²
¹Northwestern University, Chicago, IL, ²Medical University of South Carolina, Charleston, SC
*Purpose: Kidney transplant recipients (KTR) take a daily regimen of immunosuppression medication that almost inevitably includes tacrolimus (TAC). Non-adherence to TAC is a strong predictor…
2022 American Transplant Congress
Differentially Methylated Genes Predict Post-Transplant Relapse of Unresectable Hepatoblastoma
M. Ningappa¹, M. Muarya², C. Ashokkumar¹, H. Hakonarson³, S. Subramaniam⁴, R. Sindhi¹
¹Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ²Department of Bioengineering & San Diego Supercomputer Center, University of California, San Diego, CA, ³Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, ⁴Department of Computer Science and Engineering, and Nanoengineering, University of California, San Diego, La Jolla, CA
*Purpose: Hepatoblastoma (HB), a developmental liver tumor of childhood requires liver transplantation (LT) if it remains unresectable despite chemotherapy. Post-transplant relapse in up to 20%…
2022 American Transplant Congress
Cmv-Specific Cell-Mediated Immune Reconstitution in High-Risk Hematopoietic Cell Transplant Recipients Receiving Letermovir Prophylaxis
M. Z. Abidi¹, K. Garth¹, J. Gutman², A. Weinberg¹
¹Medicine, Infectious Disease, University of Colorado, Aurora, CO, ²Medicine, Hematology and Oncology, University of Colorado, Aurora, CO
*Purpose: In the absence of antiviral prophylaxis following Hematopoietic Cell Transplant (HCT), the incidence of clinically significant cytomegalovirus reactivation (cCMV) is 30% in CMV seropositive…

1
2
3
…
190
Next Page »